Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Thomas Mcnerney & Partners LLC

BioCentury | Jan 7, 2016
Financial News

Financial tracks

BioCentury | Oct 20, 2014
Financial News

Invitae completes venture financing

BioCentury | Oct 14, 2014
Financial News

Invitae raises $120M in F round

BioCentury | Jan 13, 2014
Financial News

Auspex completes venture financing

BioCentury | Jan 9, 2014
Financial News

Rare neurology disease play Auspex raises $35M

BioCentury | Dec 16, 2013
Financial News

Invitae completes venture financing

BioCentury | Dec 11, 2013
Financial News

Invitae raises $40 million E round

BioCentury | Jul 22, 2013
Financial News

Ocera completes private placement

BioCentury | Apr 29, 2013
Finance

Plenty supply; shrinking demand

Deerfield's Leff sees glass half full despite gloomy 1Q13 venture numbers
BioCentury | Nov 12, 2012
Financial News

Auspex completes venture financing

Items per page:
1 - 10 of 84